ATE541927T1 - Kardioinhibitorisches/antihypertonisches neues endogenes physiologisch aktives peptid - Google Patents

Kardioinhibitorisches/antihypertonisches neues endogenes physiologisch aktives peptid

Info

Publication number
ATE541927T1
ATE541927T1 AT05728044T AT05728044T ATE541927T1 AT E541927 T1 ATE541927 T1 AT E541927T1 AT 05728044 T AT05728044 T AT 05728044T AT 05728044 T AT05728044 T AT 05728044T AT E541927 T1 ATE541927 T1 AT E541927T1
Authority
AT
Austria
Prior art keywords
peptide
cardioinhibitory
antihypertonic
endogene
new
Prior art date
Application number
AT05728044T
Other languages
English (en)
Inventor
Masayoshi Shichiri
Original Assignee
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency filed Critical Japan Science & Tech Agency
Application granted granted Critical
Publication of ATE541927T1 publication Critical patent/ATE541927T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05728044T 2004-04-02 2005-04-01 Kardioinhibitorisches/antihypertonisches neues endogenes physiologisch aktives peptid ATE541927T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004110463 2004-04-02
PCT/JP2005/006510 WO2005095609A1 (ja) 2004-04-02 2005-04-01 心機能抑制／降圧性新規内因性生理活性ペプチド

Publications (1)

Publication Number Publication Date
ATE541927T1 true ATE541927T1 (de) 2012-02-15

Family

ID=35063786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05728044T ATE541927T1 (de) 2004-04-02 2005-04-01 Kardioinhibitorisches/antihypertonisches neues endogenes physiologisch aktives peptid

Country Status (5)

Country Link
US (1) US7829526B2 (de)
EP (1) EP1743940B1 (de)
JP (1) JP4426575B2 (de)
AT (1) ATE541927T1 (de)
WO (1) WO2005095609A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008143151A1 (ja) * 2007-05-11 2008-11-27 Proteinexpress Co., Ltd. サリューシンをターゲットとする動脈硬化性疾患の治療剤及び検出薬
KR20100061481A (ko) * 2007-09-11 2010-06-07 몬도바이오테크 래보래토리즈 아게 치료제로서의 미니가스트린
WO2009033739A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009054483A1 (ja) * 2007-10-26 2009-04-30 Proteinexpress Co., Ltd. サリューシン-βを含む医薬
WO2013151627A1 (en) * 2012-02-24 2013-10-10 Ngm Biopharmaceuticals, Inc. Methods of treating glucose metabolism disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673563A (en) 1980-10-14 1987-06-16 The University Of Virginia Alumni Patents Foundation Adenosine in the treatment of supraventricular tachycardia
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
WO2001032875A1 (en) * 1999-11-04 2001-05-10 Biogen, Inc. Torsin c nucleic acids and polypeptides
EP1239864A1 (de) 1999-11-23 2002-09-18 Aderis Pharmaceuticals, Inc. Behandlung von herzrhythmusstörungen mittels n6-substituierte-5'-(n-substituierte) carboxamidoadenosine
JP2004008027A (ja) * 2002-06-04 2004-01-15 Japan Science & Technology Corp ｃＡＭＰの産生活性を有する新規ペプチド

Also Published As

Publication number Publication date
US20080267871A1 (en) 2008-10-30
JP4426575B2 (ja) 2010-03-03
EP1743940A4 (de) 2008-01-02
EP1743940B1 (de) 2012-01-18
WO2005095609A1 (ja) 2005-10-13
US7829526B2 (en) 2010-11-09
JPWO2005095609A1 (ja) 2008-02-21
EP1743940A1 (de) 2007-01-17

Similar Documents

Publication Publication Date Title
RU2472805C2 (ru) Антибиотические пептиды
EP3226906B1 (de) Glp-1-derivate und verwendungen davon
EP3129041B1 (de) Zweifach acylierte glp-1-verbindungen
KR102066987B1 (ko) 폴리펩티드
CN102197049B (zh) 胰岛淀粉样多肽衍生物
CN105555290B (zh) 抗微生物肽
SA517390445B1 (ar) مركبات ببتيد yy انتقائية واستخداماتها
ATE479704T1 (de) Antimikrobielle peptide mit einem arginin- und /oder lysin-haltigen motiv
Panjla et al. Short peptides and their mimetics as potent antibacterial agents and antibiotic adjuvants
CY1114244T1 (el) Σκευασματα ανταγωνιστη vegf καταλληλα για ενδοϋαλωδη χορηγηση
ATE517119T1 (de) Einzelketteninsulin
CN104395338A (zh) 人胰岛淀粉样多肽类似物
WO2003087768A3 (en) Targets for therapeutic intervention identified in the mitochondrial proteome
TW200944226A (en) Biologically active peptides
BR0108959A (pt) Composições de polox‰mero ou poloxamina melhoradas para distribuição de ácido nucléico
WO2012013979A1 (en) Anti-viral agent
AR029644A1 (es) Proteina aislada, polinucleotido aislado, celula huesped transgenica, metodo para controlar una plaga que no es de mamiferos, cultivo biologicamente puro
IL206157A (en) Pancreatic elastase protein of type 1, a nucleic acid molecule encoded by a protein
ATE541927T1 (de) Kardioinhibitorisches/antihypertonisches neues endogenes physiologisch aktives peptid
EP1432729B1 (de) Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
US8815812B2 (en) Synthetic arginine substituted peptides and their use
US20160152679A1 (en) Relaxin-like compounds and uses thereof
WO2004050685A3 (en) Antifungal therapeutic agents
WO2009005798A8 (en) Antifungal formulation and method of preparation
WO2006028561A3 (en) Novel purified fabi polypeptides from fransicella tularensis